Tetanus Prophylaxis After Skin Foreign Body Removal
For skin foreign body removal, administer tetanus toxoid-containing vaccine (Td or Tdap) if the last dose was ≥5 years ago for contaminated wounds or ≥10 years ago for clean wounds; add tetanus immune globulin (TIG) 250 units IM only if the patient has <3 prior doses or unknown vaccination history. 1, 2
Wound Classification Determines Prophylaxis Timing
Foreign body wounds are typically classified as contaminated/tetanus-prone because they may harbor dirt, soil, or create anaerobic conditions favorable for Clostridium tetani growth. 3, 1 This classification is critical because it determines whether you use the 5-year or 10-year interval for booster administration.
- Contaminated wounds (most foreign bodies): Puncture wounds, wounds contaminated with dirt/soil/saliva, or wounds creating potential anaerobic environments 3, 1
- Clean, minor wounds: Superficial wounds <6 hours old with minimal tissue damage 4
Vaccination Algorithm Based on Immunization History
For Patients with ≥3 Previous Doses (Complete Primary Series)
Contaminated/tetanus-prone wounds:
- Last dose <5 years ago: No tetanus toxoid or TIG needed 3, 1, 2
- Last dose ≥5 years ago: Administer tetanus toxoid-containing vaccine WITHOUT TIG 3, 1, 2
Clean, minor wounds:
- Last dose <10 years ago: No tetanus toxoid or TIG needed 1, 2
- Last dose ≥10 years ago: Administer tetanus toxoid-containing vaccine WITHOUT TIG 1, 2
For Patients with <3 Previous Doses or Unknown History
- All wounds: Administer BOTH tetanus toxoid-containing vaccine AND TIG 250 units IM at separate sites 1, 2
- Treat uncertain vaccination history as having had no previous tetanus toxoid doses 5, 1
- Complete the 3-dose primary series: second dose at 2 months, third dose 6-8 months after second dose 2
Vaccine Selection by Age
- Adults ≥11 years: Tdap preferred if never received Tdap or Tdap history unknown (provides pertussis protection); otherwise Td acceptable 3, 2
- Adults >65 years: Td preferred 5
- Children <7 years: DTaP 3, 2
- Children 7-10 years: Td 3
- Pregnant women: Tdap regardless of prior Tdap history 3
Special Populations Requiring TIG Regardless of Vaccination History
- Immunocompromised patients (HIV infection, severe immunodeficiency) with contaminated wounds should receive TIG regardless of tetanus immunization history 3, 6
- Patients >60 years and immigrants from regions outside North America/Europe should be prioritized for TIG if supplies are limited, as they are less likely to have adequate antitetanus antibodies 5
Critical Clinical Pearls
- There is no urgency for tetanus toxoid administration in the acute setting—it provides protection against the next injury, not the current one 7
- TIG provides immediate passive immunity and must be given at a separate site with a separate syringe from tetanus toxoid 1, 2
- Do not confuse the 10-year routine booster interval with the 5-year interval for contaminated wounds—this is the most common error in tetanus prophylaxis 3, 8
- Overimmunization is the most frequent mistake (88.9% of errors), particularly giving Td to patients with clean wounds who had a booster within 10 years 8
- More frequent boosters than recommended increase the risk of Arthus-type hypersensitivity reactions 9, 2
Essential Wound Management
- Thorough wound debridement and irrigation are as critical as immunization for tetanus prevention 6, 10
- Remove all foreign material and necrotic tissue to eliminate anaerobic conditions 6
- Plain water irrigation is sufficient for most wounds 10
Common Pitfalls to Avoid
- Do not give unnecessary boosters: A patient with complete primary series and last dose <5 years ago (contaminated wound) or <10 years ago (clean wound) needs NO additional vaccination 1, 2
- Do not give TIG to fully vaccinated patients: TIG is only for those with <3 doses or unknown history 1, 2
- Do not assume military service equals complete vaccination: While persons with military service since 1941 likely received at least one dose, completion of primary series cannot be assumed 1
- Do not forget to complete the primary series: Patients requiring both vaccine and TIG must ultimately complete a 3-dose primary series 3, 2